Melanoma. Critical Debates. Challenges In

  • ID: 2221501
  • Book
  • 304 Pages
  • John Wiley and Sons Ltd
1 of 4
This book brings a new approach to the subject of melanoma, highlighting the current areas of controversy and debate. A wide spectrum, ranging from clinical investigation into the scientific basis of the disease through to its management and prognosis, is covered. In each section, al selection of controversial issues are discussed.

Internationally renowned experts critically appraise the literature and combine this with their own clinical and research experience to present an informed view of a range of issues. Arguments are therefore supported by the most recently available evidence. Melanoma: Critical Debates provides the reader with an up–to–date interpretation of the clinical trial data in this field and their relevance to daily practice.

Note: Product cover images may vary from those shown
2 of 4
Aetiology and Risk.

Chapter 1: What patterns of sun exposure really cause melanoma?.

Chapter 2: Are sunbeds dangerous?.

Chapter 3: Do sunscreens cause cancer or protect from a risk of melanoma?.

Chapter 4: Why are redheads so susceptible to melanoma?.

Chapter 5: How should we manage patients with atypical moles?.

Chapter 6: What should we know and what should we do about high–risk families?.

Chapter 7: How should we manage borderline melanocytic lesions?.


Diagnosis, Screening and Prevention.

Chapter 8: How can we improve early diagnosis?.

Chapter 9: What are the prospects for screening for melanoma at different latitudes?.



Chapter 10: What should we consider when excising the primary?.

Chapter 11: What imaging/investigation in melanoma patients?.

Chapter 12: What management for regional lymph node relapse?.

Chapter 13: What are the issues surrounding congenital naevi?.

Chapter 14: What is the role of chemotherapy?.

Chapter 15: What is the role of biological–response–modifiers in the treatment of melanoma?.

Chapter 16: Will vaccines really work for melanoma?.

Chapter 17: Who should we consider for isolated limb perfusion?.

Chapter 18: What are the novel treatment strategies are on the horizon?.

Chapter 19: Who should follow–up melanoma patients and for how long?.

Chapter 20: What is the role for radiotherapy in melanoma?.

Chapter 21: What should we tell patients about hormones after having melanoma?

Note: Product cover images may vary from those shown
3 of 4


4 of 4
"...this sounds like a fascinating book by Julia Newton–Bishop and Martin Gore who are probably at the forefront for their work in melanoma in this country.

"The book seems readable, and generally the titles for each of the chapters make me want to read it – in fact I want to read this book now!
"In terms of the authors′ competence and reputation, as I say, the editors could not be bettered."

Miss Christobel Saunders, Senior Lecturer & Honorary Consultant in Surgery, University College London

"The authors, or should we say editors, are very well known, both in this country and internationally for their interest in melanoma and they are indeed admirably qualified to write such a book. The style seems very practically orientated and in that way is likely to be popular.

"...the list of authors of chapters is excellent in that in each chosen author appears to be an expert in the area he or she has been designated so that apart from the reservation I have stated I would certainly expect the book to do well."

Professor Martin Cook, Professor of Histopathology, Royal Surrey County Hospital

"...this book is a satisfyingly complete review of the controversial issues that need to be addressed by clinicians involved in melanoma. I believe it has certainly achieved the objective I set for it when I picked it up and I have no doubt that it will be seen in all library collections where melanoma patients (and those being screened for melanoma) are being managed..." British Journal of Dermatology, 2002.

Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown